Novo Nordisk has launched a rival bid for U.S. obesity biotech firm Metsera, directly challenging an existing offer from Pfizer. The move, announced Thursday, escalates the competition between the two ...
A recently announced initiative between Pfizer and the Trump administration to lower U.S. drug prices will likely have minimal effects at the pharmacy counter, The New York Times reported Oct. 1. On ...
Eli Lilly's stock jumped over 5% on Tuesday after U.S.President Donald Trump unveiled a plan to lower U.S. drug prices, which included a “TrumpRx” direct-to-consumer website and a pricing agreement ...
Pfizer has been trying to get in on the billion-dollar weight loss drug market. Novo Nordisk initially dominated this market but has been losing ground to Eli Lilly. 10 stocks we like better than ...
(Corrects paragraph 1 to say Pfizer is suing Metsera shareholders, not its own shareholders) (Reuters) -Pfizer Inc said on Monday it has filed a second lawsuit against Metsera and its controlling ...
Pfizer announced on Wednesday that it has started clinical trials that could lead to the antiviral pill Paxlovid being available for children ages six and up to reduce the severity and duration of ...
The words "Ozempic" and "Wegovy" almost have become household names as these products have changed the lives of many – from our own friends and family to celebrities. These drugs, prescribed for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results